Acute Horner syndrome from supraclavicular lymphadenopathy as the first manifestation of metastatic lung carcinoma

Authors

  • Kathryn Hohs Illinois College of Optometry
  • Christina Morettin Yonge St. Clair Eye Center

DOI:

https://doi.org/10.15353/cjo.v87i2.6207

Keywords:

carcinoma, Horner syndrome, lymphadenopathy, supraclavicular, sympathetic

Abstract

Introduction 

Horner syndrome is a rare ocular condition consisting of pupil miosis, eyelid ptosis and facial anhidrosis. It occurs secondary to damage along the three-neuron sympathetic nerve pathway that travels a long course from the brain to the eye. If acute, the syndrome can be the presenting sign of life-threatening pathology in the head, chest, or neck. Thorough history, careful clinical exam, and proper imaging studies are essential to diagnose the syndrome, help localize the lesion and determine proper treatment for the underlying etiology.  

Case Report 

This case presents a 62-year-old female patient with an acute left-sided Horner syndrome confirmed by pharmacologic testing. She had an unremarkable medical history beyond arthritis, denied a history of trauma, and reported a tobacco smoking history. Further review of symptoms did not allow for definitive localization of the lesion, nor did she have a known underlying cause of Horner syndrome at presentation. Emergent imaging of the chest and neck revealed a preganglionic lesion caused by metastatic supraclavicular lymphadenopathy in the neck originating from primary lung carcinoma. Brain magnetic resonance imaging identified several areas of metastasis to the brain. She was treated with prompt chemotherapy and radiation. 

Conclusion 

An adult patient with acute Horner syndrome without significant localizing symptoms or pertinent review of systems requires an emergent and thorough work up to rule out malignancy. Horner syndrome as the first presenting sign of undetected malignancy along the sympathetic chain is rare. An accurate diagnosis from an optometrist and subsequent timely referral is critical to uncover potentially life-threatening pathology that may be unknown to the patient at the time of presentation.  

References

1. Kanagalingam S, Miller NR. Horner syndrome: clinical perspectives. Eye Brain. 2015;7:35-46. doi:10.2147/eb.s63633

2. Davagnanam I, Fraser CL, Miszkiel K, Daniel CS, Plant GT. Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond). Mar 2013;27(3):291-8. doi:10.1038/eye.2012.281

3. Maloney WF, Younge BR, Moyer NJ. Evaluation of the causes and accuracy of pharmacologic localization in Horner's syndrome. Am J Ophthalmol. Sep 1980;90(3):394-402. doi:10.1016/s0002-9394(14)74924-4

4. Sabbagh MA, De Lott LB, Trobe JD. Causes of Horner Syndrome: A Study of 318 Patients. J Neuroophthalmol. Sep 2020;40(3):362-369. doi:10.1097/wno.0000000000000844

5. Almog Y, Gepstein R, Kesler A. Diagnostic value of imaging in horner syndrome in adults. J Neuroophthalmol. Mar 2010;30(1):7-11. doi:10.1097/WNO.0b013e3181ce1a12

6. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician. Dec 1 2002;66(11):2103-10.

7. Kočan L, Rapčan R, Griger M, et al. Deciphering the enigmatic symptoms of Pancoast tumors: Navigating the complex landscape of pain management-A case report. Radiol Case Rep. May 2024;19(5):1810-1814. doi:10.1016/j.radcr.2024.01.091

8. Reede DL, Garcon E, Smoker WR, Kardon R. Horner's syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am. May 2008;18(2):369-85, xi. doi:10.1016/j.nic.2007.11.003

9. Vitale MG, Riccardi F, Carrillo G, et al. Horner's syndrome: An unusual presentation of metastatic disease in breast cancer. Int J Immunopathol Pharmacol. © The Author(s) 2015.; 2015:557-61. vol. 4.

10. Lele S, Derise N, Medlin T, Takalkar A, Nathan CA. Horner Syndrome Secondary to Metastatic Squamous Cell Carcinoma in the Neck: A Case Series. Ear Nose Throat J. Apr-May 2019;98(4):223-226. doi:10.1177/0145561319838248

11. Martin TJ. Horner Syndrome: A Clinical Review. ACS Chem Neurosci. Feb 21 2018;9(2):177-186. doi:10.1021/acschemneuro.7b00405

12. Mori S, Bertamino M, Guerisoli L, et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardiooncology. Feb 16 2024;10(1):8. doi:10.1186/s40959-024-00207-3

13. Gangaputra S, Babiuch A, Bradfield YS. Cervical lymphadenopathy secondary to rhabdomyosarcoma presenting as Horner syndrome in an infant. J aapos. Apr 2015;19(2):194-6. doi:10.1016/j.jaapos.2014.11.007

Published

2025-06-26

How to Cite

Hohs, K., & Morettin, C. (2025). Acute Horner syndrome from supraclavicular lymphadenopathy as the first manifestation of metastatic lung carcinoma . Canadian Journal of Optometry, 87(2), 11–25. https://doi.org/10.15353/cjo.v87i2.6207

Issue

Section

Case Reports